Recent studies have shown that the absence of SIRT1 can cause sphingomyelin to accumulate in cells, and in different cancer types or under different experimental conditions, SIRT can act as an oncogene or a tumor suppressor gene. This evidence concerns the gene SIRT1 and neoplasm.